Ainos, Inc. (AIMD)

Market Cap	5.95M
Revenue (ttm)	40,633
Net Income (ttm)	-16.13M
Shares Out	13.84M
EPS (ttm)	-2.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,147
Open	0.426
Previous Close	0.426
Day's Range	0.416 - 0.437
52-Week Range	0.400 - 4.290
Beta	1.41
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2024

About AIMD

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 46
• Stock Exchange: NASDAQ
• Ticker Symbol: AIMD
• Website: https://www.ainos.com

Financial Performance

In 2023, Ainos's revenue was $122,112, a decrease of -96.53% compared to the previous year's $3.52 million. Losses were -$13.77 million, -1.69% less than in 2022.